Vektor vaccine trial volunteers develop coronavirus antibodies

#
# 19:31
3 September 2020

All volunteers for the Stage 1 of clinical trials for the COVID-19 vaccine of Russian research center Vektor have developed antibodies, the press service of the Russian consumer health watchdog said, APA reports citing Sputnik.

Earlier on Thursday, the government agency said that all trial participants had been discharged from the hospital and feeling well.

When asked how many of the volunteers have developed antibodies, the watchdog said, "All nine of them."

#
#

THE OPERATION IS BEING PERFORMED